Ghetie V, Fabricius H A, Nilsson K, Sjöquist J
Immunology. 1974 Jun;26(6):1081-91.
Fluorescent protein A of (F1-SpA) acts on the IgG receptors of guinea-pig lymphocytes (GPL) and human lymphoid cells (Seraphina) to induce a redistribution pattern (multiple spots, patches, expelled material, caps) similar to the membrane staining of some living cells with anti-IgG. No ring staining was observed, which implies that F1-SpA acts as a multivalent cross-linking agent on IgG receptors. A prozone effect dependent on F1-SpA concentration was observed. F1-SpA staining was not abolished 2 hours after trypsinization of the cells, nor was it completely inhibited by pretreatment of the cells with non-fluorescent SpA. A low percentage of cap-like stained cells was recorded even at 4° or in the presence of sodium azide. Seventeen per cent of GPL are specifically stained with F1-SpA whereas with fluorescent anti-guinea-pig gamma-globulin serum 45 per cent of the cells are fluorescent. After immunization of the animals with sheep red blood cells (SRBC) 31 per cent of the GPL became positive with F1-SpA. Forty per cent of Seraphina cells were stained, whether fluorescent anti-human gamma chain serum or F1-SpA were used. It was also shown that the Fab fragment of an anti-human gamma chain preparation partially inhibited the specific staining of the Seraphina cells with F1-SpA. This suggests that both reagents have a common site of action (IgG receptors). F1-SpA did not stain human lymphoid cells which bear IgM receptors (Daudi cells); SpA reacts only with the Fc region of IgG. However, by reacting Daudi cells with an anti-IgM serum (containing IgG antibodies) and afterwards with F1-SpA, specific staining was achieved. F1-SpA is therefore recommended as a fluorescent reagent for indirect immunofluorescent staining in which IgG antibodies are used.
(某种物质的)荧光蛋白A(F1-SpA)作用于豚鼠淋巴细胞(GPL)和人类淋巴细胞(Seraphina)的IgG受体,诱导出一种再分布模式(多个斑点、斑块、排出物质、帽状结构),类似于一些活细胞用抗IgG进行膜染色的模式。未观察到环状染色,这意味着F1-SpA在IgG受体上作为一种多价交联剂起作用。观察到了一种依赖于F1-SpA浓度的前带效应。细胞经胰蛋白酶处理2小时后,F1-SpA染色并未消除,用非荧光SpA预处理细胞也不能完全抑制F1-SpA染色。即使在4℃或存在叠氮化钠的情况下,也记录到了低比例的帽状染色细胞。17%的GPL被F1-SpA特异性染色,而用荧光抗豚鼠γ球蛋白血清时,45%的细胞发荧光。用绵羊红细胞(SRBC)免疫动物后,31%的GPL对F1-SpA呈阳性反应。无论使用荧光抗人γ链血清还是F1-SpA,40%的Seraphina细胞都被染色。还表明,抗人γ链制剂的Fab片段部分抑制了Seraphina细胞被F1-SpA的特异性染色。这表明两种试剂具有共同的作用位点(IgG受体)。F1-SpA不染色带有IgM受体的人类淋巴细胞(Daudi细胞);SpA仅与IgG的Fc区域反应。然而,通过使Daudi细胞与抗IgM血清(含IgG抗体)反应,然后再与F1-SpA反应,实现了特异性染色。因此,F1-SpA被推荐作为一种荧光试剂,用于使用IgG抗体的间接免疫荧光染色。